TriVascular Technologies

TriVascular’s initial product offerings are novel endovascular grafts focused on significantly advancing EVAR. Building upon partnerships with thought leading clinicians worldwide, TriVascular’s products are designed to address unmet clinical needs and expand the pool of patients who are candidates for EVAR.

Type
Subsidiary
Parent Company
Endologix
HQ
Irvine, US
Founded
1998
Size (employees)
307 (est)
TriVascular Technologies was founded in 1998 and is headquartered in Santa Rosa, US

TriVascular Technologies Office Locations

TriVascular Technologies has offices in Santa Rosa, Irvine, Rosmalen
Santa Rosa, US
Irvine, US
Rosmalen, NL

TriVascular Technologies Metrics

TriVascular Technologies Summary

Founding Date

1998
TriVascular Technologies is a subsidiary of Endologix

Market Position – medical devices, healthtech, medical diagnostics, Manufacturing & Industrial, Health

TriVascular Technologies News

TriVascular Technologies Company Life

You may also be interested in